The effect of fiber-rich carbohydrates on features of Syndrome X

Journal of the American Dietetic Association

Volumn 103, Issue 1, 2003, Pages 86-96

  Davy, Brenda M ^a   Melby, Christopher L ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARBOHYDRATE; GLUCOSE; INSULIN; LIPOPROTEIN;

ABDOMEN; ADIPOSE TISSUE; ARTERIAL PRESSURE; BODY FAT; BODY WEIGHT; CARBOHYDRATE DIET; CLINICAL FEATURE; CLINICAL TRIAL; DIETARY FIBER; DISEASE ACTIVITY; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; FIBRINOLYSIS; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEREDITY; HIGH FIBER DIET; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MEDICAL RESEARCH; META ANALYSIS; METABOLIC DISORDER; METABOLIC SYNDROME X; MOLECULAR DYNAMICS; PREVALENCE; REVIEW; RISK FACTOR; BLOOD; DIET THERAPY; HISTOLOGY; METABOLISM; OBESITY; PATHOPHYSIOLOGY;

ABDOMEN; ADIPOSE TISSUE; BLOOD GLUCOSE; DIETARY CARBOHYDRATES; DIETARY FIBER; HUMANS; LIPOPROTEINS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 0037271270     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1053/jada.2003.50005     Document Type: Article

References (115)

1. Reaven G.M. Diet and Syndrome X. CURR ATHEROSCLER REP. 2:2000;503-507.
2. Krauss R.M., Dreon D.M. Low-density lipoprotein subclasses and responses to a low-fat diet in healthy men. AM J CLIN NUTR. 62:1995;478S-487S.
3. Krauss R.M. Atherogenic lipoprotein phenotype and diet-gene interactions. J NUTR. 131:2001;340S-343S.
4. Mittendorfer B., Sidossis L.S. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short term, high-carbohydrate diets. AM J CLIN NUTR. 73:2001;892-899.
5. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. AM J CLIN NUTR. 71:2000;412-433.
6. Riccardi G., Rivellese A.A. Dietary treatment of the metabolic syndrome-the optimal diet. BR J NUTR. 83:(suppl 1):2000;S143-148.
7. Blundell J.E., Macdiarmid J.I. Fat as a risk factor for overconsumption: satiation, satiety, and patterns of eating. J AM DIET ASSOC. 97:(suppl):1997;S63-69.
8. Wing R.R., Hill J.O. Successful weight loss maintenance. ANNU REV NUTR. 21:2001;323-341.
9. Anderson J.W. Dietary fiber prevents carbohydrate-induced hypertriglyceridemia. CURR ATHEROSCLER REP. 2:2000;536-541.
10. Davy B., Davy K., Ho R., Beske S., Davrath L., Melby C. A high-fiber diet containing oats as compared to wheat favorably alters low-density lipoprotein cholesterol subclass and particle number in middle aged and older men. AM J CLIN NUTR. 76:2002;351-358.
11. Frayn K.N. Visceral fat and insulin resistance-causative or correlative? BR J NUTR. 83:(suppl):2000;S71-77.
12. Bjorntorp P., Rosmond R. The metabolic syndrome-a neuroendocrine disorder? BR J NUTR. 83:(suppl 1):2000;S49-S57.
13. Lemieux I., Pascot A., Prud'homme D., Almeras N., Bogaty P., Nadeau A., Bergeron J., Depres J.P. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. ARTERIOSCLER THROMB VASC BIOL. 21:2001;961-967.
14. Beck-Nielsen H. General characteristics of the insulin resistance syndrome: prevalence and heritability. DRUGS. 58:(suppl 1):1999;7-10.
15. Schmidt M.I., Duncan B.B., Watson R.L., Sharrett A.R., Brancati F.L., Heiss G. A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. DIABETES CARE. 19:1996;414-418.
16. Greenlund K.J., Valdez R., Casper M., Rith-Najarian S., Croft J.B. Prevalence and correlates of the insulin resistance syndrome among Native Americans. DIABETES CARE. 22:1999;441-447.
17. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the Metabolic Syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 287:2002;356-359.
18. Pyorala M., Miettinen H., Halonene P., Laakso M., Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stoke in healthy middle-aged men. ARTERIOSCLER THROMB VASC BIOL. 20:2000;538-544.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
20. Ukkola O., Bouchard C. Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. ANN MED. 33:2001;79-90.
21. Bouchard C. Genetics and the metabolic syndrome. INT J OBES. 19:(suppl I):1995;S52-59.
22. Bogardus C., Lillioja S., Mott D.M., Hollenbeck C., Reaven G. Relationship between degree of obesity and in vivo insulin action in man. AM J PHYSIOL ENDOCRINOL METAB. 11:1985;E286-291.
23. Belfiore F., Iannello S. Insulin resistance in obesity: metabolic mechanisms and measurement methods. MOL GENET METAB. 65:1998;121-128.
24. Ferrannini E., Barrett E.J., Bevilacqua S., DeFronzo R.A. Effect of fatty acids on glucose production and utilization in man. J CLIN INVEST. 72:1983;1737-1747.
25. Wiesenthal S.R., Sandhu H., McCall R.H., Tchipashvili V., Yoshii H., Polonsky K., Shi Z.Q., Lewis G.F., Mari A., Giacca A. Free fatty acids impair hepatic insulin extraction in vivo. DIABETES. 48:1999;766-774.
26. Pouliot M.C., Depres J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., Nadeau A., Lupien P.J. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. AM J CARDIOL. 73:1994;460-468.
27. Shepherd P.R., Kahn B.B. Glucose transporters and insulin action. N ENGL J MED. 341:1999;248-257.
28. Jones C.N.O., Abbasi F., Carantoni M., Polonsky K.S., Reaven G.M. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. AM J PHYSIOL. 278:2000;E501-508.
29. Ginsberg H.N. Insulin resistance and cardiovascular disease. J CLIN INVEST. 106:2000;453-458.
30. Hulthe J., Bokemark L., Wikstrand J., Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis. ARTERIOSCLER THROMB VASC BIOL. 20:2000;2140-2147.
31. Parks E.J., Krauss R.M., Christiansen M.P., Neese R.A., Hellerstein M.K. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J CLIN INVEST. 104:1999;1087-1096.
32. Lamarche B., Lewis G.F. Atherosclerosis prevention for the next decade: risk assessment beyond low-density lipoprotein cholesterol. CAN J CARDIOL. 14:1998;841-851.
33. Mamo J.C.L., Yu K.C.U., Elsegood C.L., Smith D., Vine D., Gennat H.C., Voevodin M., Proctor S.D. Is atherosclerosis exclusively a postprandial phenomenon? CLIN EXP PHARMACOL PHYSIOL. 24:1997;288-293.
34. Mediratta S., Fozailoff A., Frishman W. Insulin resistance in systemic hypertension: pharmacotherapeutic implications. J CLIN PHARMACOL. 35:1995;943-956.
35. Scherrer U., Sartori C. Insulin as a vascular and sympathoexcitatory hormone. CIRCULATION. 96:1997;4104-4113.
36. Ferrannini E. Insulin resistance and blood pressure. Reaven G., Laws A. INSULIN RESISTANCE: THE METABOLIC SYNDROME X. 1999;Humana Press, Totowa, NJ.
37. Landin K., Stigendal L., Eriksson E., Krotkiewski M., Risberg B., Tengborn L., Smith U. Abdominal obesity is associated with an impaired fibrinolyitc activity and elevated plasminogen activator inhibitor-1. METABOLISM. 39:1990;1044-1048.
38. Juhan-Vague I., Alessi M.C., Morange P.E. PAI-1, Obesity, and insulin resistance. Reaven G., Laws A. CONTEMPORARY ENDOCRINOLOGY: INSULIN RESISTANCE. 1999;Humana Press, Totawa, NJ.
39. Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., Juhan-Vague I. Production of plasminogen activator inhibitor I by human adipose tissue: possible link between visceral fat accumulation and vascular disease. DIABETES. 46:1997;860-867.
40. Mohamed-Ali V., Pinkney J.H., Copack S.W. Adipose tissue as an endocrine and paracrine organ. INT J OBESITY. 22:1998;1145-1158.
41. Position of the American Dietetic Association. Health implications of dietary fiber. J AM DIET ASSOC. 97:1997;1157-1159.
42. Anderson J.W., Smith B.M., Gustafson N.J. Health benefits and practical aspects of high-fiber diets. AM J CLIN NUTR. 599:(suppl):1994;1242S-1247S.
43. Sparti A., Milon H., Di Vetta V., Schneiter P., Tappy L., Jequir E., Schutz Y. Effect of diets high or low in unavailable and slowly digestible carbohydrates on the pattern of 24-h substrate oxidation and feelings of hunger in humans. AM J CLIN NUTR. 72:2000;1461-1468.
44. Liu S., Stampfer M.J., Hu F.B., Giovannucci E., Rimm E., Manson J.E., Hennekens C.H., Willett W.C. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. AM J CLIN NUTR. 70:1999;412-419.
45. Van Horn L. Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. CIRCULATION. 95:1997;2701-2704.
46. Salmeron J., Acherio A., Rimm E.B., Colditz G.A., Spiegelman D., Jenkins D.J., Stampfer M.J., Wing A.L., Willett W.C. Dietary fiber, glycemic load, and risk of NIDDM in men. DIABETES CARE. 20:1997;545-550.
47. Salmeron J., Manson J.E., Stampfer M.J., Colditz G.A., Wing A.L., Willett W.C. Dietary fiber, glycemic load, and risk of non-insulin dependent diabetes mellitus in women. JAMA. 277:1997;472-477.
48. Ascherio A., Rimm E.B., Hernan M.A., Giovannucci E.L., Kawachi I., Stampfer M.J., Willett W.C. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. CIRCULATION. 98:1998;1198-1204.
49. Howe G.R., Hirohata T., Hislop T.G., Iscovich J.M., Yuan J.M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J NATL CANCER INST. 82:1990;561-569.
50. Howe G.R., Benito E., Castelleto R., Cornee J., Esteve J., Gallagher R.P., Iscovich J.M., Deng-ao J., Kaaks R. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J NATL CANCER INST. 84:1992;1887-1896.
51. Rose D.P. Dietary fiber, phytoestrogens, and breast cancer. NUTRITION. 8:1992;47-51.
52. McKeowyn-Eyssen G.E., Bright-See E., Bruce W.R., Jazmaji V. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group. J CLIN EPIDEMIOL. 47:1994;525-536.
53. Willett W.C., Hunter D.J., Stampfer M.J., Colditz G., Manson J.E., Spiegelman D., Rosner B., Hennekens C.H., Speizer F.E. Dietary fat and fiber in relation to risk of breast cancer: An 8-year follow-up. JAMA. 268:1992;2037-2044.
54. Anderson J.W., Spencer D., Hamilton C.C., Smith S.F., Tietyen J., Bryant C.A., Oeltgen P. Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. AM J CLIN NUTR. 52:1990;459-495.
55. Anderson J.W., Gilinsky N.H., Deakins D.A., Smith S.F., Spencer O'Neal D., Dillon D., Oeltgen P.R. Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. AM J CLIN NUTR. 54:1991;678-683.
56. Brown L., Rosner B., Willett W.C., Sacks F.M. Cholesterol-lowering effects of dietary fiber: a meta-analysis. AM J CLIN NUTR. 69:1999;30-42.
57. Kashtan H., Stern H.S., Jenkins D.J.A., Jenkins A.L., Hay K., Marcon N., Minkin S., Bruce W.R. Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins. AM J CLIN NUTR. 55:1992;976-980.
58. Jenkins D.J.A., Kendall C.W.C., Vuksan V., Augustin L.S.A., Mehling C., Parker T., Vidgen E., Lee B., Faulkner D., Seyler H., Josse R., Leiter L.A., Connelly P.W., Fulgoni V. Effect of wheat bran on serum lipids: influence of particle size and wheat properties. J AM COLL NUTR. 18:1999;159-165.
59. Vuksan V., Jenkins D.J.A., Vidgen E., Ransom T.P.P., Ng M.K., Culhane C.T., O'Connor D. A novel source of wheat fiber and protein: effects on fecal bulk and serum lipids. AM J CLIN NUTR. 69:1999;226-230.
60. Coulston A.M., Reaven G.M. Much ado about (almost) nothing. DIABETES CARE. 20:1997;241-242.
61. Wolever T.M.S. The glycemic index: Flogging a dead horse? DIABETES CARE. 20:1997;452-456.
62. Jarvi A., Karlstrom B., Granfeldt Y., Bjorck I., Asp N.G., Vessby B. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. DIABETES CARE. 22:1999;10-18.
63. Liljeberg H.G., Akerberg A.K., Bjorck I.M. Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. AM J CLIN NUTR. 69:1999;647-655.
64. Luscombe N.D., Noakes M., Clifton P.M. Diets high and low in glycemic index vs high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM. EUR J CLIN NUTR. 53:1999;473-478.
65. Meyer K.A., Kushi L.H., Jacons D.R., Slavin J., Sellers T.A., Folsom A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. AM J CLIN NUTR. 71:2000;921-930.
66. Djousse L., Ellison C., Zhang Y., Arnett D.K., Sholinsky P., Borecki I. Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung and Blood Institute Family Heart Study. AM J CLIN NUTR. 68:1998;568-575.
67. Marckmann P., Sandstrom B., Jesperson J. Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. AM J CLIN NUTR. 59:1994;935-939.
68. Mennen L.I., Wittemen J.C., den Breeijen J.H., Schouten E.G., de Jong P.T., Hofman A., Grobbee D.E. The association of dietary fat and fiber with coagulation factor VII in the elderly: the Rotterdam Study. AM J CLIN NUTR. 65:1997;726-732.
69. Jenkins D.J.A., Axelson M., Kendall C.W.C., Augustin L.S.A., Vuksan V., Smith U. Dietary fibre, lente carbohydrates and the insulin resistant diseases. BR J NUTR. 83:(suppl I):2000;S157-163.
70. Reaven G.M. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. CURR OPIN LIPIDOL. 8:1997;23-27.
71. Garg A., Bantle J.P., Henry R.R., Coulston A.M., Griver K.A., Raatz S.K., Brinkly L., Chen Y.D., Grundy S.M., Huet B.A. Effects of varying carbohydrate content in patients with non-insulin dependent diabetes mellitus. JAMA. 271:1994;1421-1428.
72. Garg A., Grundy S.M., Unger R.H. Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. DIABETES. 41:1992;1278-1285.
73. Ginsberg H.N. The step 1 diet and a high monounsaturated fat diet have equal effects on postprandial triglyceride, glucose and insulin levels in individuals with markers for insulin resistance (abstract). FASEB J. 10:1996;A462.
74. Lovejoy J., DiGirolamo M. Habitual dietary intake and insulin sensitivity in lean and obese adults. AM J CLIN NUTR. 55:1992;1174-1179.
75. Fukagawa N.K., Anderson J.W., Hagemen G., Young V., Minaker K.L. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. AM J CLIN NUTR. 52:1990;524-528.
76. Strazinsky N., O'Callaghan C., Barrington V., Louis W. Hypotensive effect of a low-fat, high-carbohydrate diet can be independent of changes in plasma insulin concentrations. HYPERTENSION. 34:1999;580-585.
77. Song Y., Sawamura M., Ikeda K., Igawa S., Yamori Y. Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats. CLIN EXP PHARMACOL PHYSIOL. 27:2000;41-45.
78. Austin M., Breslow J., Hennekens C., Buring J., Willett W., Krauss R. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260:1988;1917-1921.
79. Gardner C., Fortmann S., Krauss R. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 276:1996;875-881.
80. Gotto A.M. Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease. CIRCULATION. 103:2001;2213-2218.
81. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G., Lupien P., Despres J.P. Small dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. CIRCULATION. 95:1997;69-75.
82. Mack W., Krauss R., Hodis H. L:ipoprotein subclasses in the Monitored Atherosclerosis Regression Study. ARTERIOSCLER THROMB VASC BIOL. 16:1996;697-704.
83. Stampfer M., Krauss R., Ma J., Blanche P., Holl L., Sacks F., Hennekens C. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 276:1996;882-888.
84. Chandalia M., Garg A., Lutjohann D., Von Bergmann K., Grundy S.M. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N ENGL J MED. 342:2000;1392-1398.
85. Anderson J., Hanna T. Impact on nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease. J NUTR. 129:1999;1457S-1466S.
86. Ripsin C., Keenan J., Jacobs D., Elmer P., Welch R., Van Horn L., Liu K., Turnbull W., Thye F., Kestin M., Hegsted M., Davidson D., Davidson M., Dugan L., Demark-Wahnefried W., Beling S. Oat products and lipid lowering: a meta analysis. JAMA. 267:1992;3317-3325.
87. Lovegrove J., Clohessy A., Milon H., Williams C. Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins. AM J CLIN NUTR. 72:2000;49-55.
88. Jeppesen J., Hollenbeck C., Zhou M., Coulston A., Jones C., Chen I., Reaven G. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. ARTERIOSCLER THROMB VASC BIOL. 15:1995;320-324.
89. Lemieux I., Couillard C., Pascot A., Bergeron N., Prud'homme D., Bergeron J., Tremblay A., Bouchard C., Mauriege P., Despres J.P. The small, dense LDL phenotype as a correlate of postprandial lipemia in men. ATHEROSCLEROSIS. 153:2000;423-432.
90. Abbasi F., McLaughlin T., Lamendola C., Kim H.S., Tanaka A., Wang T., Nakajima K., Reaven G.M. High carbohydrate diets, triglyderide-rich lipoproteins, and coronary heart disease risk. AM J CARDIOL. 85:2000;45-48.
91. Gerhard G., Connor S., Wander R., Connor W. Plasma lipid and lipoprotein responsiveness to dietary fat and cholesterol in premenopausal African American and white women. AM J CLIN NUTR. 72:2000;56-63.
92. Dreon D., Krauss R. Diet-gene interactions in human lipoprotein metabolism. J AM COLL NUTR. 16:1997;313-324.
93. Dreon D., Fernstrom H., Miller B., Krauss R. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J. 8:1994;121-126.
94. Dreon D., Fernstrom H., Miller B., Krauss R. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. ARTERIOSCLER THROMB VASC BIOL. 15:1995;105-111.
95. Hu F., Rimm E., Stampfer M., Ascherio A., Spiegelman D., Willett W. Prospective study of major dietary patterns and risk of coronary heart disease in men. AM J CLIN NUTR. 72:2000;912-921.
96. Rimm E., Ascherio A., Giovannucci E., Spiegelman D., Stampfer M., Willett W. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 275:1996;447-451.
97. Wolk A., Manson J., Stampfer M., Colditz G., Hu F., Speizer F., Hennekens C., Willett W. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA. 281:1999;1998-2004.
98. Pietinen P., Rimm E., Korhonene P., Hartman A., Willett W., Albanes D., Virtamo J. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. CIRCULATION. 94:1996;2720-2727.
99. Ascherio A., Rimm E.B., Giovannucci E.L., Colditz G., Rosner B., Willett W., Sacks F., Stampfer M. A prospective study of nutritional factors and hypertension among US men. CIRCULATION. 86:1992;1475-1484.
100. Ascherio A., Hennekens C., Willett W., Sacks F., Rosner B., Manson J., Wittemen J., Stampfer M. Prospective study of nutritional factors, blood pressure, and hypertension among US women. HYPERTENSION. 27:1996;1065-1072.
101. He J., Klag M., Whelton P., Mo J., Chen J., Qian M., Mo P., He G. Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China. AM J CLIN NUTR. 61:1995;366-372.
102. Kestin M., Moss R., Clifton P., Nestel P. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. AM J CLIN NUTR. 52:1990;661-666.
103. Swain J., Rouse I., Curley C., Sacks F. Comparison of the effects of oat bran and low-fiber wheat bran on serum lipoprotein levels and blood pressure. JAMA. 322:1990;147-152.
104. Fehily A., Burr M., Butland B., Eastham R. A randomized controlled trial to investigate the effect of a high fibre diet on blood pressure and plasma fibrinogen. J EPIDEMIOL COMMUN HEALTH. 40:1986;334-337.
105. Davy B., Melby C., Beske S., Ho R., Davrath L., Davy K. Oat consumption does not affect resting casual and ambulatory 24-hour arterial blood pressure in men with high-normal blood pressure to stage I hypertension. J NUTR. 132:2002;394-398.
106. Appel L., Moore T., Obarzanek E., Vollmer W., Svetkey L., Sacks F., Bray G., Vogt T., Cutler J., Windhauser M., Lin P., Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N ENGL J MED. 336:1997;1117-1124.
107. Saltzman E., Das S., Lichtenstein A., Dallal G., Corrales A., Schaefer E., Greenberg A., Roberts S. An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J NUTR. 131:2001;1465-1470.
108. McLaughlin T., Abbasi F., Carantoni M., Schaaf P., Reaven G. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J CLIN ENDOCRINOL METAB. 84:1999;578-581.
109. Purnell J.Q., Brunzell J.D. The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome. CURR OPIN LIPIDOL. 8:1997;17-22.
110. United States Department of Agriculture, Agricultural Research Service, Food surveys Research Group. Results from USDA's 1994-96 Continuing Survey of Food Intakes by Individuals, table set 10. http://www.barc.usda.gov/bhnrc/ foodsurvey/home.htm:November 1, 2001;. Available at Accessed.
111. American Heart Association. AHA dietary guidelines. CIRCULATION. 102:2000;2296-2311.
112. Jacobs D.R., Meyer K.A., Kushi L.H., Folsom A.R. Is whole grain intake associated with reduced total and cause-specific death rates in older women? The Iowa Women's Health Study. AM J PUBLIC HEALTH. 89:1999;322-329.
113. Jacobs D.R., Meyer K.A., Kushi L.H., Folsom A.R. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. AM J CLIN NUTR. 68:1998;248-257.
114. Moore T., Vollmer W., Appel L., Sacks F., Svetky L., Vogt T., Conlin P., Simons-Morton D., Carter-Edwards L., Harsha D. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension Trial. HYPERTENSION. 34:1999;472-477.
115. Obarzanek E., Sacks F., Vollmer W., Bray G., Miller E., Lin P., Karanja N., Windhauser M., Moore T., Swain J., Bales C., Proschan M. Effects on blood lipids of a blood-pressure-lowering diet: the Dietary Approaches to Stop Hypertension Trial. AM J CLIN NUTR. 74:2001;80-89.